Skip to main content
. 2024 Jul 20;27(8):110559. doi: 10.1016/j.isci.2024.110559

Figure 4.

Figure 4

18F-fluciclovine net uptake rate in supraclavicular adipose tissue as a marker of adiposity and metabolic health

(A) SCV adipose tissue net uptake rate for 18F-fluciclovine in patients in the normal (n = 9), overweight (n = 16), and obese (n = 10) BMI category. p values determined by using one-way analysis of variance with Tukey correction for multiple comparisons.

(B) Correlation between SCV adipose tissue net uptake rate for 18F-fluciclovine and BMI (n = 35). Spearman’s rho was used to evaluate the correlation between the different variables of interest.

(C) SCV adipose tissue net uptake rate for 18F-fluciclovine in patients with (n = 5) and without diagnosis of T2D (n = 29). The medical record of one of the participants was not available. p value was determined by using Mann-Whitney U test. Data are means ± SD for normally distributed data or median (interquartile range) for skewed data. AT, adipose tissue; BMI, body mass index; Ki, net uptake rate reflecting clearance from blood; NW, normal weight; OB, obesity; OW, overweight; SCV, supraclavicular; T2D, type 2 diabetes. ∗p < 0.05 and ∗∗p < 0.01.